Pharmaceutical Executive Magazine

Home
United States
Cranbury, NJ
Pharmaceutical Executive Magazine

Master the Science of Success

09/12/2024

A recent study by Morningstar predicts that 16 new weight-loss drugs could be on the market by 2029.

09/11/2024

The latest news for pharma industry insiders.

09/10/2024

The latest news for pharma industry insiders.

09/05/2024

A C-suite Q&A with Cristina Ortega Duran, President of Evinova, a separate health-tech business which AstraZeneca recently launched to accelerate innovation across the life sciences sector and the delivery of 💬🗨️

A C-suite Q&A with Cristina Ortega Duran, President of Evinova.

09/05/2024

The latest news for pharma industry insiders.

09/04/2024

The company partnered with Marius Pharmaceuticals to offer access to Kyzatrex.

09/04/2024

The “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.

09/04/2024

The latest news for pharma industry insiders.

09/03/2024

After a post-pandemic slow down, the pharma industry saw a return of mergers and acquisitions late last year and early this year. Cheryl Reicin, international chair of life sciences at Mintz, spoke with Pharmaceutical Executive about the current trends in the industry 💬🗨️

As the second half of 2024 begins, an industry expert discusses how mergers and acquisitions are trending in the pharma industry.

09/03/2024

The latest news for pharma industry insiders.

08/30/2024

Strategies that can help maintain and grow your market share. Plus how to adapt to new competitive pressures and evolving customer needs.

08/30/2024

The latest news for pharma industry insiders.

08/29/2024

Due to increasing complexity of modern technology, FDA should consider updating its 510(k) process 🖋️Currien MacDonald, Medical chair director, WCG

Due to increasing complexity of modern technology, FDA should consider updating its 510(k) process.

08/29/2024

The latest news for pharma industry insiders.

08/28/2024

This makes Aetna the first major insurer to cover these types of services.

08/28/2024

The latest news for pharma industry insiders.

08/27/2024

The latest news for pharma industry insiders.

08/27/2024

Achieving better outcomes for patients and advancing the fields of and are not just about adopting new technologies, but also about embracing a profound change in how care is delivered🖋️Mark Crockett, MD, Chief Medical Officer, TeleDaaS

Achieving better outcomes for patients and advancing the fields of nuclear medicine and oncology are not just about adopting new technologies, but also about embracing a profound change in how care is delivered.

Address

2 Clarke Drive #100
Cranbury, NJ
08512

Telephone

+16097167777

Website

http://www.pharmexec.com/

Alerts

Be the first to know and let us send you an email when Pharmaceutical Executive Magazine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Pharmaceutical Executive Magazine:

Videos

Read our October issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-october-2024?utm_source=organic&utm_medium=facebook&utm_campaign=mktg_sizzle

Read our September issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-september-2024?utm_source=organic&utm_medium=facebook&utm_campaign=mktg_sizzle

Read our July/August issue: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-julyaugust-2024?utm_source=organic&utm_medium=facebook&utm_campaign=mktg_sizzle

Check out our June issue with an exclusive interview with Mark Cuban! More than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur shares his recipe for true disruption to the pharma pricing machine. Read the full story in our latest issue: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-june-2024?utm_source=organic&utm_medium=facebook&utm_campaign=mktg_sizzle #MarkCuban #DrugPricing #PharmaInnovation #TransparentPricing

The 2024 Pharma 50 is out now! Highlighted by notable company and product maneuvering at the top, and the continued dramatic growth of therapeutic settings such as GLP-1s, Pharm Exec’s latest listing of the top global biopharma sales producers is proof-positive of an industry in transition. In this year’s Pharma 50, witness the power shifts, innovative breakthroughs, and market leaders redefining the biopharma landscape. Discover how these companies are pushing the boundaries of healthcare, driving unprecedented growth, and shaping the future of medicine.

Read our May issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-may-2024?utm_source=organic&utm_medium=facebook&utm_campaign=mktg_sizzle

Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more. 🎙️ https://www.pharmexec.com/view/healthcare-marketing-strategies-for-reaching-diverse-audiences

In this episode of the Pharmaceutical Executive Podcast, Currax Pharmaceuticals LLC CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more. Listen to the podcast: https://ow.ly/tV3Q50Rsx0X #PatientSuccess #Obesity #WeightlossDrugs

Industry executives dive into trends like utilizing AI and influencers for content creation, personalizing messages to the patient, combatting the spread of misinformation and much more in the video version of our executive roundtable discussion Participants: Ian Baer, Founder and Chief Soothsayer, Sooth® Andrew Bast, Chief Strategy Officer, Greater Than One Jay Shah, Senior Solutions Engineer, MMIT (Managed Markets Insight & Technology) Simon Arkell OLY, CEO and Co-Founder, Ryght Glen Saunders, VP of Product Management and Strategy, Skipta John Kenny, PhD, SVP and Head of Strategic Planning, EVERSANA INTOUCH 📹 View the full conversation here: https://www.pharmexec.com/view/roundtable-current-state-of-the-pharma-sales-and-marketing-sales-force?utm_source=social&utm_medium=social&utm_campaign=mktg_video